Staar Surgical CoSTAA
Price$22.38Intrinsic value$38.2271% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $339.6M+8.2% YoYTTM through 3 Jul 2026
Net Income $3.8MTTM through 3 Jul 2026
Free Cash Flow -$6.7MTTM through 3 Jul 2026

Margins

Current
Gross Margin73.6%
EBITDA Margin6.4%
Operating Margin8.5%
Net Margin1.1%

Returns

-6.1%ROE
-4.7%ROA
1.5%ROIC

Balance Sheet Health

Debt / Equity0.11x
Current Ratio5.05x
Net Debt-$126.6Mnet cash position
Cash & Equivalents$148.6M

Quality Metrics

Altman Z-Score6.75
Piotroski F-Score4 / 9
FCF Margin-2.0%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'20'21'21'22'23'24'26
FY2026: $239.4M
Diluted EPS$0.08TTM
'20'21'21'22'23'24'26
FY2026: $-1.62

Dividend

No dividend

Capital Allocation

R&D Spend$38.3M
Capex Intensity1.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.